TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Community Healthcare Trust Inc (CHCT)

Real Estate REIT - Healthcare Facilities
18.30 $
-1.3% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at Community Healthcare Trust Inc.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 2 of our scanner strategies — each hit links to the scanner.

Dividends
Risk & Weakness

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

Trading Day

Previous Close
18.60$
Open
18.60$
Day High
18.60$
Day Low
18.30$
Volume
166,573shares

Key levels of the most recently completed trading day — not a live quote.

52-Week Range

52-Week Low 52-Week High
13.30 $ 19.00 $
10/10/2025 07/28/2026

Current price 18.30 $ — 88% of the range above the low.

Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.

Basics

Market Cap
0.5$B
Shares Outstanding
29Mio.
Float
88.4%
Beta
0.7

Performance

Perf. 1M
6.40%
Perf. 3M
22.50%
Perf. 6M
24.00%
YTD Performance (%)
15.00%
52-Week-High Distance
-1.8%
Perf. 1Y
34.32%
Perf. 3Y
-30.66%
Perf. 5Y
-46.46%
Perf. 10Y
50.04%
Perf. Since Inception
94.73%

Technical Indicators

MA 38 Days
18.10$
MA 50 Days
18.00$
MA 200 Days
16.70$
RSI (14)
49.6
Volatility 30 Days
22.7%
Volatility 250 Days
24.0%

Calculated from the price history · as of 08/03/2026

Valuation

very high
P/E
152.5
Forward P/E
37.3
PEG
P/B
1.2
P/S
4.3
EV/EBITDA
13.9
Price/FCF
9.4

Profitability

Gross Margin
80.5%
EBIT Margin
Net Margin
4.9%
Return on Equity
1.4%
Return on Assets
2.0%

Balance Sheet & Safety

Equity Ratio
Debt/Equity
1.3
Altman Z″
1.53
Piotroski
7 out of 9

Growth

Sales Growth Last Quarter
4.80%
EPS Growth Last Quarter
119.10%
Sales Growth (Year)
4.67%
Forward Sales Growth
5.79%
Forward EPS Growth
54.30%

Dividend

Dividend Yield
10.40%
Dividend Per Share (TTM)
1.91$
Payout Ratio
2.9%
Years Without a Cut
10Years
Increase Streak
10Years

Quality & Screener

Stage
2
RS Rating
62
EPS Rating
87
Piotroski
7 out of 9
Fundamental Rating
B (58 out of 100)
Altman Z″
1.53

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Growth Score

3 of 10 Weak growth

Ten checks against the annual reports — each one passed counts a point.

  • Revenue grows by more than 15% a year over three years 7.5% failed
  • More than 10% revenue growth is expected for the coming year 5.8% failed
  • Share count grows by less than 3% a year 4.4% failed
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 34.3% failed
  • Gross margin at 40% or higher and without meaningful erosion 8.7% failed
  • Goodwill from acquisitions does not grow faster than revenue 0.0% passed
  • Net debt below twice EBITDA 6.4 x EBITDA failed
  • Operating cash flow covers the profits of the last three years 167 m passed
  • Return on capital at 15% or higher, or up versus two years ago 2.9% passed
  • Insiders hold at least 10% or are net buyers 6.1% failed

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Analysts & Price Target

Current Price 18.30 $
Price Target (average) 19.25 $

The price target sits 5.2% above the current price.

Consensus
Sell
Analyst Ratings
5
Distribution of Recommendations
Strong Buy 2
Buy 1
Hold 2
Sell 0
Strong Sell 0

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 129 4
12/31/2027 136 4

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Next Reporting Date

4. Aug 2026 · after the close · Q2 2026
Expected Earnings per Share
0.47 $

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 29.3 $M Q4 2025: Q1 · 30.1 $M Q1 2025: Q2 · 29.1 $M Q2 2025: Q3 · 30.8 $M Q3 2025: Q4 · 30.9 $M Q4 2026: Q1 · 31.5 $M Q1

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 0.07 -60.90 29 0.60 6.30 16 11
2025: Q1 0.06 -57.30 30 2.50 5.30 14 10
2025: Q2 -0.47 29 5.70 -43.20 14 10
2025: Q3 0.06 -7.20 31 4.00 5.30 13 8
2025: Q4 0.54 682.40 31 5.60 46.60 16 30
2026: Q1 0.09 58.60 32 4.80 8.10 14 9
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Annual Figures

Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 25 4 3 0.24 15 194 252
2017 37 7 4 0.24 22 283 386
2018 49 13 4 0.25 24 272 427
2019 61 19 8 0.45 32 353 563
2020 76 28 19 0.88 48 430 668
2021 91 33 22 0.97 56 462 754
2022 98 34 22 0.93 60 497 876
2023 113 25 8 0.31 61 513 945
2024 116 20 -3 -0.12 59 476 993
2025 121 20 5 0.19 56 429 991

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

About the Company

Community Healthcare Trust Incorporated is a real estate investment trust. It focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States.

Employees35
HeadquartersFranklin, TN
Address3326 Aspen Grove Drive, 37067-2870 Franklin, United States
Phone615 771 3052
Websitechct.reit
IPO Date21. May 2015
ISINUS20369C1062

Management

Management
Name Title Birth Year
David H. Dupuy CEO, President & Director 1969
William G. Monroe IV Executive VP, CFO & Corporate Secretary 1979
Leigh Ann Stach Executive VP & Chief Accounting Officer 1967
Mark E. Kearns Senior Vice President of Asset Management
Gary Moothart VP & Controller

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?